Log in
Enquire now
‌

US Patent 9968608 Pharmaceutical compositions comprising pemetrexed and tromethamine

Patent 9968608 was granted and assigned to Fresenius Kabi Oncology PLC on May, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Fresenius Kabi Oncology PLC
Fresenius Kabi Oncology PLC
Current Assignee
Fresenius Kabi Oncology PLC
Fresenius Kabi Oncology PLC
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9968608
Date of Patent
May 15, 2018
Patent Application Number
15200433
Date Filed
July 1, 2016
Patent Citations Received
‌
US Patent 11931362 Stable pharmaceutical formulations of pemetrexed
0
Patent Primary Examiner
‌
Douglas M Willis
Patent abstract

A pharmaceutical composition of Pemetrexed represented by formula (I), which is a liquid ready to use solution formulation or a lyophilized pharmaceutical composition for parenteral administration comprising a pharmaceutically acceptable organic amine, an inert gas and optionally containing at least one or more pharmaceutically acceptable excipients. Also provided are processes for preparation of the ready to use solution formulation or lyophilized pharmaceutical composition of the present invention.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9968608 Pharmaceutical compositions comprising pemetrexed and tromethamine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us